Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yokohama-ACS: Statin Comparison in Acute Coronary Syndrome
NCT00549926Phase 4Completed
- Sponsor
- Yokohama City University Medical Center
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluvastatin, pravastatin, pitavastatin and atorvastatin in acute coronary syndrome (ACS) and hypercholesterolemia (4 arms), sponsored by Yokohama City University Medical Center. Primary endpoints: Percent change in coronary plaque volume and Percent change in integrated backscatter signal. Started Oct 2007; status: completed.
02
Drugs
fluvastatinpravastatinpitavastatinatorvastatin
03
Conditions
acute coronary syndrome (ACS)hypercholesterolemia
Beyond the preview
Go deeper on NCT00549926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549926.